Cargando…

Efficacy and Safety of AlbisD Compared With Omeprazole 20 mg in Patients With Non-erosive Reflux Disease: A Randomized, Open-label, Active-controlled, Pilot Study

BACKGROUND/AIMS: Proton pump inhibitors (PPIs) are frequently used to treat non-erosive reflux disease (NERD), but their effect is limited. It is not known whether a potential alternative, AlbisD, containing ranitidine hydrochloride, sucralfate hydrate, and tripotassium dicitrato bismuthate, is effe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Eun Jin, Lee, Oh Young, Lee, Kang Nyeong, Lee, Sung Joon, Jang, Jae-Young, Cho, Jin Woong, Kim, Tae-Oh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Society of Neurogastroenterology and Motility 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6657924/ https://www.ncbi.nlm.nih.gov/pubmed/31327222 http://dx.doi.org/10.5056/jnm18185

Ejemplares similares

Gastroesophageal Reflux Disease Relief in Patients Treated with Rabeprazole 20 mg versus Omeprazole 20 mg: A Meta-Analysis
por: Xia, X. M., et al.
Publicado: (2013)

A Randomized, Double-Blind, Active-Control, Noninferiority, Multicenter, Phase 4 Study to Evaluate the Efficacy and Safety of Esomeprazole/Sodium Bicarbonate 20/800 mg in Patients with Nonerosive Gastroesophageal Reflux Disease
por: Park, Su Hyun, et al.
Publicado: (2023)

Comparison of Direct Medical Care Costs Between Erosive Reflux Disease and Non-erosive Reflux Disease in Korean Tertiary Medical Center
por: Seo, Pyoung Ju, et al.
Publicado: (2010)

Differences in Clinical Characteristics between Patients with Non-Erosive Reflux Disease and Erosive Esophagitis in Korea
por: Ha, Na Rae, et al.
Publicado: (2010)

Delayed-release oral suspension of omeprazole for the treatment of erosive esophagitis and gastroesophageal reflux disease in pediatric patients: a review
por: Monzani, Alice, et al.
Publicado: (2010)

The Impact of Erosive Reflux Esophagitis on the Decline of Lung Function in the General Population
por: Kang, Hye-Rin, et al.
Publicado: (2021)

Efficacy of S-pantoprazole 10 mg in the Symptom Control of Non-erosive Reflux Disease: A Phase III Placebo-controlled Trial
por: Cho, Yu Kyung, et al.
Publicado: (2021)

Buccal Buspirone as add–on Therapy to Omeprazole Versus Omeprazole in Treatment of Gastroesophageal Reflux Diseases (GERD)
por: Abdi, Saeed, et al.
Publicado: (2020)

Proton Beam Therapy for Treatment-Naïve Hepatocellular Carcinoma and Prognostic Significance of Albumin-Bilirubin (ALBI) Grade
por: Kim, Tae Hyun, et al.
Publicado: (2022)

In albis : poemas, 1979-1990 /
por: Magaña, Gabriel, 1944-

The Relationship of the Post-reflux Swallow-induced Peristaltic Wave Index and Esophageal Baseline Impedance with Gastroesophageal Reflux Disease Symptoms
por: Cho, Young Kyu, et al.
Publicado: (2017)

Treatment of non-erosive reflux disease and dynamics of the esophageal microbiome: a prospective multicenter study
por: Park, Chan Hyuk, et al.
Publicado: (2020)

Electrolyte disturbances in children receiving omeprazole for gastroesophageal reflux disease
por: Famouri, Fatemeh, et al.
Publicado: (2020)

Central Obesity as a Risk Factor for Non-Erosive Reflux Disease
por: Kim, Ki Ju, et al.
Publicado: (2017)

Overlap of Erosive and Non-erosive Reflux Diseases With Functional Gastrointestinal Disorders According to Rome III Criteria
por: Noh, Young Wook, et al.
Publicado: (2010)

Randomised clinical trial: comparison of tegoprazan and placebo in non‐erosive reflux disease
por: Kim, Seung Han, et al.
Publicado: (2021)

Confocal Laser Endomicroscopic Findings of Refractory Erosive Reflux Disease versus Non-Erosive Reflux Disease with Anti-Reflux Mucosectomy: An in vivo and ex vivo Study
por: Jeong, Eunju, et al.
Publicado: (2021)

Gender-specific Effect of Micronutrient on Non-erosive Reflux Disease and Erosive Esophagitis
por: Nam, Su Youn, et al.
Publicado: (2019)

Triglyceride-glucose index is associated with gastroesophageal reflux disease and erosive reflux disease: a health checkup cohort study
por: Kim, Young Min, et al.
Publicado: (2022)

Omeprazole-Domperidone Fixed Dose Combination vs Omeprazole Monotherapy: A Phase 4, Open-Label, Comparative, Parallel Randomized Controlled Study in Mild to Moderate Gastroesophageal Reflux Disease
por: Marakhouski, KY, et al.
Publicado: (2017)

Controlling on-demand gastric acidity in obese subjects: a randomized, controlled trial comparing a single dose of 20 mg rabeprazole and 20 mg omeprazole
por: Belhocine, Kafia, et al.
Publicado: (2014)

Randomized controlled trial to evaluate the efficacy and safety of fexuprazan compared with esomeprazole in erosive esophagitis
por: Lee, Kang Nyeong, et al.
Publicado: (2022)

Erosive esophageal reflux vs. non erosive esophageal reflux: oral findings in 71 patients
por: Deppe, Herbert, et al.
Publicado: (2015)

Comparative evaluation of ALBI, MELD, and Child-Pugh scores in prognosis of cirrhosis: is ALBI the new alternative?
por: Fragaki, Maria, et al.
Publicado: (2019)

The Relationship Between Existence of Typical Symptoms and Psychological Factors in Patients With Erosive Esophagitis
por: Lee, Sang Pyo, et al.
Publicado: (2012)

Effects of CYP2C19 Genetic Polymorphisms on PK/PD Responses of Omeprazole in Korean Healthy Volunteers
por: Park, Sunny, et al.
Publicado: (2017)

Effect of a Combination of Omeprazole Plus Sustained Release Baclofen Versus Omeprazole Alone on Symptoms of Patients with Gastroesophageal Reflux Disease (GERD)
por: Abbasinazari, Mohammad, et al.
Publicado: (2014)

A randomized prospective study comparing the efficacy of on-demand therapy versus continuous therapy for 6 months for long-term maintenance with omeprazole 20 mg in patients with gastroesophageal reflux disease in Japan
por: Nagahara, Akihito, et al.
Publicado: (2014)

Effects of omeprazole and AlOH/MgOH on riociguat absorption
por: Becker, Corina, et al.
Publicado: (2013)

Omeprazole and adenocarcinoma in the stomach of rats submitted to duodenogastric reflux. Is there a protective effect?
por: Monteiro, Rosângela Lucinda Rocha, et al.
Publicado: (2020)

Rectal Omeprazole in Infants With Gastroesophageal Reflux Disease: A Randomized Pilot Trial
por: Bestebreurtje, Petra, et al.
Publicado: (2020)

Clinical Implications of the Gastroesophageal Reflux Disease Questionnaire and Reflux Symptom Index in Patients With Suspected Laryngopharyngeal Reflux Symptoms
por: Kim, Young Dong, et al.
Publicado: (2022)

Association Between Non-erosive Reflux Disease and High Risk of Obstructive Sleep Apnea in Korean Population
por: You, Chan Ran, et al.
Publicado: (2014)

Gastroesophageal Reflux Disease and Tooth Erosion
por: Ranjitkar, Sarbin, et al.
Publicado: (2012)

Effects of Omeprazole Over Voice Quality in Muscle Tension Dysphonia Patients With Laryngopharyngeal Reflux
por: Kandogan, Tolga, et al.
Publicado: (2012)

Prevalence of Gastroesophageal Reflux in Cats During Anesthesia and Effect of Omeprazole on Gastric pH
por: Garcia, R.S., et al.
Publicado: (2017)

Role of non-acid reflux in patients with non-erosive reflux disease
por: Karamanolis, Georgios P., et al.
Publicado: (2013)

Characteristics of Symptomatic Belching in Patients With Belching Disorder and Patients Who Exhibit Gastroesophageal Reflux Disease With Belching
por: Jeong, Shin Ok, et al.
Publicado: (2021)

Prognostic Prediction for Patients with Hepatocellular Carcinoma and Ascites: Role of Albumin-Bilirubin (ALBI) Grade and Easy (EZ)-ALBI Grade
por: Liao, Jia-I, et al.
Publicado: (2023)

Irritable Bowel Syndrome Is Associated With Gastroesophageal Reflux Symptom but Not Erosive Esophagitis
por: Nam, Su Youn, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_8alcje74rbvektaj333ba503nm